References
- Kligman AM. Pathologic dynamics of human hair loss. I. Telogen effluvium. Arch Dermatol. 1961;83(2):175–198. doi:10.1001/archderm.1961.01580080005001
- Grover C, Khurana A. Telogen effluvium. Indian J Dermatol Venereol Leprol. 2013;79(5):591–603. doi:10.4103/0378-6323.116731
- Hughes EC, Saleh D. Telogen effluvium. In: Treasure Island (FL); 2022.
- Headington JT. Telogen effluvium. New concepts and review. Arch Dermatol. 1993;129(3):356–363. doi:10.1001/archderm.1993.01680240096017
- Asghar F, Shamim N, Farooque U, Sheikh H, Aqeel R. Telogen effluvium: a review of the literature. Cureus. 2020;12(5):e8320. doi:10.7759/cureus.8320
- Malkud S. Telogen effluvium: a review. J Clin Diagn Res. 2015;9(9):WE01–WE03. doi:10.7860/JCDR/2015/15219.6492
- Burroway B, Griggs J, Martinez-Velasco MA, Tosti A. Telogen effluvium. In: Hair and Scalp Treatments. Cham: Springer International Publishing; 2020:125–138.
- Bayart C, Bergfeld WF. Telogen Effluvium. In: McMichael AJ, Hordinsky MK, editors. Hair and Scalp Disorders. 2nd ed. London: CRC Press; 2018:123–138.
- Perera E, Sinclair R. Treatment of chronic telogen effluvium with oral minoxidil: a retrospective study. F1000Res. 2017;6:1650. doi:10.12688/f1000research.11775.1
- Nestor MS, Ablon G, Gade A, Han H, Fischer DL. Treatment options for androgenetic alopecia: efficacy, side effects, compliance, financial considerations, and ethics. J Cosmet Dermatol. 2021;20(12):3759–3781. doi:10.1111/jocd.14537
- Gentile P. Hair Loss and Telogen Effluvium Related to COVID-19: the Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies. Int J Mol Sci. 2022;23(16):9116. doi:10.3390/ijms23169116
- Fukuoka H, Narita K, Suga H. Hair regeneration therapy: application of adipose-derived stem cells. Curr Stem Cell Res Ther. 2017;12(7):531–534. doi:10.2174/1574888X12666170522114307
- Fukuoka H, Suga H, Narita K, Watanabe R, Shintani S. The latest advance in hair regeneration therapy using proteins secreted by adipose-derived stem cells. Am J Cosmetic Surg. 2012;29(4):273–282. doi:10.5992/AJCS-D-12-00015.1
- Festa E, Fretz J, Berry R, et al. Adipocyte lineage cells contribute to the skin stem cell niche to drive hair cycling. Cell. 2011;146(5):761–771. doi:10.1016/j.cell.2011.07.019
- Fukuoka H, Suga H. Hair regeneration treatment using adipose-derived stem cell conditioned medium: follow-up with trichograms. Eplasty. 2015;15:e10.
- Nepal S, Venkataram A, Mysore V. The role of adipose tissue in hair regeneration: a potential tool for management?. J Cutan Aesthet Surg. 2021;14(3):295–304. doi:10.4103/JCAS.JCAS_47_19
- Shrivastava S. Diffuse hair loss in an adult female: approach to diagnosis and management. Indian J Dermatol Venereol Leprol. 2009;75(1):20. doi:10.4103/0378-6323.45215
- Cranwell WC, Sinclair R. Telogen effluvium. In: Alopecia. Elsevier Health Sciences; 2019:83–93
- Narita K, Fukuoka H, Sekiyama T, Suga H, Harii K. Sequential scalp assessment in hair regeneration therapy using an adipose-derived stem cell-conditioned medium. Dermatol Surg. 2020;46(6):819–825. doi:10.1097/DSS.0000000000002128
- Tak YJ, Lee SY, Cho AR, Kim YS. A randomized, double-blind, vehicle-controlled clinical study of hair regeneration using adipose-derived stem cell constituent extract in androgenetic alopecia. Stem Cells Transl Med. 2020;9(8):839–849. doi:10.1002/sctm.19-0410
- Shin H, Ryu HH, Kwon O, Park BS, Jo SJ. Clinical use of conditioned media of adipose tissue-derived stem cells in female pattern hair loss: a retrospective case series study. Int J Dermatol. 2015;54(6):730–735. doi:10.1111/ijd.12650
- Zanzottera F, Lavezzari E, Trovato L, Icardi A, Graziano A. Adipose derived stem cells and growth factors applied on hair transplantation. Follow-up of clinical outcome. J Cosmet Dermatol Sci Appl. 2014;4(04):268–274. doi:10.4236/jcdsa.2014.44036
- Lee YI, Kim J, Kim J, Park S, Lee JH. The effect of conditioned media from human adipocyte-derived mesenchymal stem cells on androgenetic alopecia after nonablative fractional laser treatment. Dermatol Surg. 2020;46(12):1698–1704. doi:10.1097/DSS.0000000000002518
- Anderi R, Makdissy N, Azar A, Rizk F, Hamade A. Cellular therapy with human autologous adipose-derived adult cells of stromal vascular fraction for alopecia areata. Stem Cell Res Ther. 2018;9(1):141. doi:10.1186/s13287-018-0889-y
- Won CH, Park GH, Wu X, et al. The basic mechanism of hair growth stimulation by adipose-derived stem cells and their secretory factors. Curr Stem Cell Res Ther. 2017;12(7):535–543. doi:10.2174/1574888X12666170829161058
- Nilforoushzadeh MA, Aghdami N, Taghiabadi E. Effects of adipose-derived stem cells and platelet-rich plasma exosomes on the inductivity of hair dermal papilla cells. Cell J. 2021;23(5):576–583. doi:10.22074/cellj.2021.7352
- Moon KM, Park YH, Lee JS, et al. The effect of secretory factors of adipose-derived stem cells on human keratinocytes. Int J Mol Sci. 2012;13(1):1239–1257. doi:10.3390/ijms13011239
- Liu J, Xiao Q, Xiao J, et al. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther. 2022;7(1):3. doi:10.1038/s41392-021-00762-6
- Hong LW, Xiang LJ, Shi HX, et al. Fibroblast growth factors stimulate hair growth through β-catenin and Shh expression in C57BL/6 mice. Biomed Res Int. 2015;2015:730139. doi:10.1155/2015/730139
- Gnann LA, Castro RF, Azzalis LA, et al. Hematological and hepatic effects of vascular epidermal growth factor (VEGF) used to stimulate hair growth in an animal model. BMC Dermatol. 2013;13(1):15. doi:10.1186/1471-5945-13-15
- González R, Moffatt G, Hagner A, et al. Platelet-derived growth factor signaling modulates adult hair follicle dermal stem cell maintenance and self-renewal. NPJ Regen Med. 2017;2(1):11. doi:10.1038/s41536-017-0013-4
- Trüeb RM. Further clinical evidence for the effect of IGF-1 on hair growth and alopecia. Skin Appendage Disord. 2018;4(2):90–95. doi:10.1159/000479333
- Kubanov AA, Gallyamova YA, Korableva OA, Kalinina PA. The role of the VEGF, KGF, EGF, and TGF-β1 growth factors in the pathogenesis of telogen effluvium in women. Biomed Pharmacol J. 2017;10(1):191–198. doi:10.13005/bpj/1097
- Alessandrini AM, Bruni F, Piraccini BM, Starace M. The effectiveness and tolerability of preformed growth factors vehiculated through iontophoresis on patients with androgenetic alopecia and telogen effluvium: a clinical study. Dermatol Pract Concept. 2021;11(3):e2021082. doi:10.5826/dpc.1103a82
- Kubanov AA, Gallyamova YA, Korableva OA. A randomized study of biomimetic peptides efficacy and impact on the growth factors expression in the hair follicles of patients with telogen effluvium. J Appl Pharm Sci. 2018;8(4):15–22.
- El-Refai AM, Elhabak DM, Khashaba RA. More is not always better in hair growth factors. epidermal growth factor: hair growth factor involved in alopecia areata pathogenesis. Int J Trichol. 2020;12(4):182–187. doi:10.4103/ijt.ijt_51_20
- Harrison S, Sinclair R. Telogen effluvium. Clin Exp Dermatol. 2002;27(5):389–395. doi:10.1046/j.1365-2230.2002.01080.x
- Fatani MI, Bin Mahfoz AM, Mahdi AH, et al. Prevalence and factors associated with telogen effluvium in adult females at Makkah region, Saudi Arabia: a retrospective study. J Dermatol Dermatol Surg. 2015;19(1):27–30. doi:10.1016/j.jdds.2014.04.002
- Patel M, Harrison S, Sinclair R. Drugs and hair loss. Dermatol Clin. 2013;31(1):67–73. doi:10.1016/j.det.2012.08.002
- Whiting DA. Chronic telogen effluvium. Dermatol Clin. 1996;14(4):723–731. doi:10.1016/S0733-8635(05)70398-3
- Glimore S, Sinclair R. Chronic telogen effluvium is due to a reduction in the variance of anagen duration. Australas J Dermatol. 2010;51(3):163–167. doi:10.1111/j.1440-0960.2010.00654.x
- Xiao S, Deng Y, Mo X, et al. Promotion of hair growth by conditioned medium from extracellular matrix/stromal vascular fraction gel in C57BL/6 Mice. Stem Cells Int. 2020;2020:1–11. doi:10.1155/2020/9054514
- Rebora A. Telogen effluvium: a comprehensive review. Clin Cosmet Investig Dermatol. 2019;12:583–590. doi:10.2147/CCID.S200471
- Fertig RM, Gamret AC, Cervantes J, Tosti A. Microneedling for the treatment of hair loss?. J Eur Acad Dermatol Venereol. 2018;32(4):564–569. doi:10.1111/jdv.14722
- Dhurat R, Sukesh M, Avhad G, Dandale A, Pal A, Pund P. A randomized evaluator blinded study of effect of microneedling in androgenetic alopecia: a pilot study. Int J Trichol. 2013;5(1):6–11. doi:10.4103/0974-7753.114700
- Gupta AK, Quinlan EM, Venkataraman M, Bamimore MA. Microneedling for hair loss. J Cosmet Dermatol. 2022;21(1):108–117. doi:10.1111/jocd.14525